The Texas Heart Institute Implants BiVACOR® Total Artificial Heart First-in-human novel valveless artificial heart implanted in a patient with end-stage heart failure as a bridge to heart transplant Houston, Texas, July 25, 2024 – The Texas Heart Institute (THI) and BiVACOR®, a clinical-stage medical … Continue reading →